Innovations in NASH: The Role of Emerging Drug Classes in Patient Outcomes
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease characterized by inflammation and fat buildup in the liver, which can lead to cirrhosis, liver failure, and even liver cancer if left untreated. With the growing prevalence of obesity and diabetes globally, NASH has become a significant public health concern. The NASH treatment market has seen remarkable…